Categories: EHRNewsPharmaceutical

Intra-Cellular Therapies to Host Second Quarter 2023 Financial Results Conference Call and Webcast

NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Thursday, August 3, 2023, to provide a corporate update and discuss details of the Company’s financial results for the quarter ended June 30, 2023.

To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.

The live and archived webcast can be accessed under “Events & Presentations” in the Investor Relations section of the Company’s website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
212-213-0006

Staff

Recent Posts

Lions Celebrate a Successful Year of Service at the 106th Lions International Convention

OAK BROOK, Ill., June 25, 2024 /PRNewswire/ -- Lions International celebrated several milestones during the…

1 hour ago

INDUSTRY LEADER IN PATIENT CENTRICITY CALLS FOR ITS SYSTEM-WIDE ADOPTION IN NEW BOOK

Dr. Anthony Yanni publishes a wide-ranging case for patient-centered healthcare delivery and treatment development—a "long-overdue…

1 hour ago

CUNY SPH receives $5.2 million NIH grant renewal for cancer genomics research

NEW YORK, June 25, 2024 /PRNewswire/ -- The Informatics Technology for Cancer Research (ITCR) program…

1 hour ago

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

World's First AI to Detect 35 Cardiac Determinations, Including Heart Attack, Using a Reduced Leadset…

1 hour ago

WellSync makes available its virtual care service to Publix customers

New service enhances access to high-quality and affordable virtual care throughout the Southeast. TAMPA, Fla.,…

1 hour ago

FrontRunnerHC Joins athenahealth’s Marketplace Program to Unlock Efficiencies, Strengthen Financial Performance, and Improve the Patient Experience

Provides access to accurate patient insurance, demographic, and financial information for a better bottom line…

1 hour ago